MI-LINEAGE-LOGISTICS
10.11.2021 16:44:04 CET | Business Wire | Press release
Lineage Logistics, LLC, the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the installation of groundbreaking clean energy advancements at its facility in Colton, CA to establish the first facility in the Lineage network to generate 100% of its energy consumption on-site.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110005987/en/
This announcement comes in tandem with Lineage’s commitment to becoming net-zero carbon by 2040 as a signatory of The Climate Pledge, representing the Company’s industry-leading charge for a more sustainable cold chain.
Aligned with President Biden’s announcement on October 13, 2021 to invest in a secure and sustainable supply chain in the United States, Lineage has installed a 3.3MW solar array and 460kW of linear generators at its Colton Agua Mansa facility in California’s Inland Empire that, combined, will produce 100% of the facility’s energy consumption on a net basis. These advancements are indicative of Lineage’s continued prioritization of energy reduction, which started with the introduction of the Company’s responsible energy reduction roadmap in 2015.
“Lineage always strives to be responsible leaders in the communities where we live and work, and our commitment to advancing the future of renewable energy at our locations is no exception,” said Chris Thurston, head of renewable energy projects for Lineage. “Lineage is already a model for the industry with our innovative development and deployment of industry-leading technologies. Responsibly creating our own energy is an important sustainability milestone, and I am excited to see how this achievement further inspires our commitment to carbon neutrality by 2040.”
Lineage partnered with PowerFlex, a national provider of renewable energy infrastructure, to install the rooftop solar array in Colton – the second largest solar array in the Company’s leading global network of temperature-controlled warehouses. The facility has 8,426 individual solar panels that will generate an estimated 5.4 million kilowatt-hours (kWh) of clean energy annually. The Colton array is one of several onsite solar installations that PowerFlex is supporting across Lineage’s distribution centers in the United States.
“As Lineage’s long-term partner in renewable energy, we are incredibly proud to share and help execute their bold vision for impactful solar solutions across their extensive network,” said PowerFlex Director Danny Ptak. “The onsite solar project in Colton demonstrates Lineage’s ongoing commitment to deploying innovative solutions to ensure that its operations are as sustainable as humanly possible.”
The onsite linear generators, a new technology launched in March by Mainspring Energy, create electricity using a low-temperature reaction of fuel and air. Distinct from an engine or fuel cell, a linear generator directly converts motion into electricity using chemical or thermal energy. The units ramp up and down usage to enable maximum use of the building’s solar array, ensuring reliability and optimal use of renewable power at all times. This increases the site’s resiliency by reducing grid dependency and lowers operating costs. Lineage’s Colton location is the first facility in the world with two linear generators, and the first of its kind to integrate a linear generator with solar panels. The two generators were installed in October.
“Commercial and industrial buildings account for more than a third of electricity usage in the United States and play an essential role in the energy transition,” said Mainspring CEO Shannon Miller. “Mainspring designed the linear generator to accelerate this transition by delivering resilient, sustainable, and affordable generation that is also ideal for pairing with solar and other renewables. We are proud to partner with Lineage, an industry leader and pioneer in deploying innovative energy technologies.”
In December 2020, Lineage’s increased its commitment to energy reduction by implementing new and innovative technologies. In 2021, Lineage was recognized by the United States Department of Energy for Outstanding Accomplishments in Energy Efficiency for the third year in a row and the Department of Energy’s Better Plants Challenge with a commitment to reduce energy intensity by 25% by 2024.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 19 countries across North America, Europe and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was listed as No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com )
About PowerFlex
PowerFlex delivers commercial and industrial customers a full range of turnkey clean energy solutions: solar, storage, smart EV charging, microgrids, and energy management systems. The Company was founded in 2017 by a Caltech research group who developed a patented Adaptive Load Management (ALM) technology to optimize power consumption across a large network of charging stations. PowerFlex Systems was acquired by EDF Renewables North America in 2019, and consolidated with EnterSolar, a leading commercial solar developer, in 2021 to expand its onsite solar offerings. For more information, visit www.powerflex.com .
About Mainspring Energy
Driven by its vision of the affordable, reliable, net-zero carbon grid of the future, Mainspring is delivering a new category of power generation — the linear generator — that delivers onsite, dispatchable, fuel-flexible power at low cost. Based in Menlo Park, Calif., Mainspring is backed by top-tier venture, strategic, and financial investors. www.mainspringenergy.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005987/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom